Posted by Matt Dempsey matthew_dempsey@epw.senate.gov (4:24 ET)

EPA Responds to Inhofe Letter on The Safety Of Our Nation’s
Drinking Water Supply

 
Following a March 10, 2008, Associated Press article
reporting that traces of pharmaceutical contaminants were found in municipal
water systems across the country, Senator Inhofe sent a letter
to Administrator Johnson expressing his concern about the report and asking EPA
to convene a working group of relevant agencies and industry to look for potential
solutions to reduce overall pharmaceuticals in our water supply. 

On April 4, Assistant Administrator for Water, Benjamin H.
Grumbles, sent this letter in response. Mr. Grumbles pointed out that,
“[a]lthough the Associated Press series brought broad attention to this issue,
EPA has been working with other agencies and stakeholders over the past several
years to better understand the implications of emerging contaminants such as
pharmaceuticals and other personal care products that are detected in our
waters.” He also pointed out that, “while there is much information about the
health effects of pharmaceutical products at the therapeutic doses provided in
medication, there is still uncertainty about their potential effects on public
health and aquatic life from long-term exposure to the low levels observed in
water. In the absence of fully understanding the risks associated with low
levels, it is difficult to move forward to require monitoring and/or treatment
that carry significant cost, particularly when the Agency also needs to carry
out activities to address contaminants with known risk.”

The letter goes on to detail EPA’s activities that address
pharmaceuticals and personal care products in drinking water, including the
cross government coordination of the Pharmaceuticals in the Environment working
group, to research at the Office of Research and development to working with
the White House Office on National Drug Control policy to help with disposal
guidelines.

Tomorrow, April 15, 2008, at 3:00pm ET [Note the Time
Change], Assistant Administrator Grumbles will appear before the Subcommittee
on Transportation Safety, Infrastructure Security, and Water Quality hearing
entitled, “Pharmaceuticals
in the Nation’s Water: Assessing Potential Risks and Actions to Address the
Issue.”
Tomorrow’s hearing should provide Grumbles the opportunity to
expand on the issue in more detail. Also testifying at the hearing tomorrow:
 Dr. Robert Hirsch, Associate Director for Water, U.S.
Geological Survey. The witnesses also include: Jennifer Sass Ph.D., Senior
Scientist, Natural Resources Defense Council; Alan Goldhammer Ph.D., Deputy
Vice President, Regulatory Affairs, Pharmaceutical Research and Manufacturers
of America; Shane Snyder Ph.D., R&D Project Manager, Applied Research and
Development Center, Southern Nevada Water Authority; and David Pringle,
Campaign Director, New Jersey Environmental Federation.